📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. (2019)

First Author: Miao L
Attributed to:  E-TERM, Engineering Tissue Engineering and Regenerative Medicine funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41587-019-0247-3

PubMed Identifier: 31570898

Publication URI: http://europepmc.org/abstract/MED/31570898

Type: Journal Article/Review

Volume: 37

Parent Publication: Nature biotechnology

Issue: 10

ISSN: 1087-0156